Pub Date : 2025-09-26DOI: 10.1186/s42155-025-00597-0
Alice M Jacob, Alexander M C Böhner, Narine Mesropyan, Anna-Maria Odenthal, Alexander Isaak, Patrick Kupczyk, Daniel Kuetting, Julian Luetkens, Carsten Meyer, Tatjana Dell
Background: Genicular artery embolization (GAE) is an emerging, effective pain treatment for symptomatic knee osteoarthritis. A potential concern of this procedure is non-target embolization of cutaneous and subcutaneous vessels, which can lead to severe skin complications such as necrosis. To mitigate this risk, some operators use periarticular cooling with the rationale of inducing vasoconstriction. The vasoconstrictive effect on non-target subcutaneous vessels caused by cooling has, however, not yet been objectively demonstrated. This study aims to provide the first objective evidence for this common safety maneuver.
Methodology: This retrospective analysis is based on a cohort of 36 patients (39 knees). The study evaluated a total of 49 selective angiographies of medial or lateral genicular arteries, which were stratified based on the presence of a superficial blush. Three cohorts were defined for comparison: 1) The Cooling Cohort, comprising 20 angiographies (from 10 knees) that showed a blush and were treated with periarticular cooling. 2) The Blush-Control Cohort, consisting of 18 angiographies (from 18 knees) with a blush but without a cooling maneuver. 3) The No-Blush Control Cohort (11 knees). The blush area on DSA was quantitatively analyzed for both groups with a superficial blush; in the Cooling Cohort, the area was compared before and after the intervention, while the baseline blush was quantified for the Blush-Control Cohort. Skin-related adverse events were systematically recorded and compared at the patient level across all three cohorts.
Results: The application of periarticular cooling resulted in a significant reduction in the mean blush area from 464.8 ± 447.6 mm2 to 240.1 ± 208.2 mm2 (p = 0.012), corresponding to an average reduction of 73.8% (p = 0.0006). Patients receiving cooling showed significantly fewer skin alterations than the blush-control group [median score 1 vs 2, p = 0.0174].
Conclusion: Periarticular cooling is a simple, non-invasive, and effective technique that significantly reduces quantifiable non-target cutaneous perfusion during GAE. Our work provides objective evidence supporting its use as a standard safety-enhancing maneuver to minimize the risk of skin-related complications.
背景:膝动脉栓塞术(GAE)是一种新兴的、有效的治疗症状性膝骨关节炎疼痛的方法。该手术的一个潜在问题是皮下和皮下血管的非靶栓塞,这可能导致严重的皮肤并发症,如坏死。为了降低这种风险,一些作业者采用关节周围冷却,其原理是诱导血管收缩。然而,冷却对非靶皮下血管的收缩作用尚未得到客观证明。本研究旨在为这种常见的安全操作提供第一个客观证据。方法:回顾性分析基于36例患者(39个膝关节)的队列。该研究评估了49个选择性膝内侧或外侧动脉血管造影术,这些血管造影术是基于浅表腮红的存在而分层的。定义了三个队列进行比较:1)冷却队列,包括20个血管造影(来自10个膝盖),显示红肿并接受关节周围冷却治疗。2)腮红对照组,包括18张血管造影术(来自18个膝盖),有腮红但没有冷却操作。3)无脸红对照组(11膝)。定量分析两组浅表腮红在DSA上的腮红面积;在降温组中,对干预前后的腮红面积进行比较,而在腮红控制组中,对基线腮红进行量化。系统地记录皮肤相关不良事件,并在患者水平上对所有三个队列进行比较。结果:应用关节周围冷却使平均腮红面积从464.8±447.6 mm2显著减少到240.1±208.2 mm2 (p = 0.012),相当于平均减少73.8% (p = 0.0006)。接受降温治疗的患者皮肤变化明显少于脸红对照组[中位评分1 vs 2, p = 0.0174]。结论:关节周围冷却是一种简单、无创、有效的技术,可显著减少GAE期间可量化的非靶皮肤灌注。我们的工作提供了客观证据,支持其作为标准的安全增强操作,以尽量减少皮肤相关并发症的风险。
{"title":"Periarticular cooling reduces non-target perfusion in genicular artery embolization: a quantitative angiographic study.","authors":"Alice M Jacob, Alexander M C Böhner, Narine Mesropyan, Anna-Maria Odenthal, Alexander Isaak, Patrick Kupczyk, Daniel Kuetting, Julian Luetkens, Carsten Meyer, Tatjana Dell","doi":"10.1186/s42155-025-00597-0","DOIUrl":"10.1186/s42155-025-00597-0","url":null,"abstract":"<p><strong>Background: </strong>Genicular artery embolization (GAE) is an emerging, effective pain treatment for symptomatic knee osteoarthritis. A potential concern of this procedure is non-target embolization of cutaneous and subcutaneous vessels, which can lead to severe skin complications such as necrosis. To mitigate this risk, some operators use periarticular cooling with the rationale of inducing vasoconstriction. The vasoconstrictive effect on non-target subcutaneous vessels caused by cooling has, however, not yet been objectively demonstrated. This study aims to provide the first objective evidence for this common safety maneuver.</p><p><strong>Methodology: </strong>This retrospective analysis is based on a cohort of 36 patients (39 knees). The study evaluated a total of 49 selective angiographies of medial or lateral genicular arteries, which were stratified based on the presence of a superficial blush. Three cohorts were defined for comparison: 1) The Cooling Cohort, comprising 20 angiographies (from 10 knees) that showed a blush and were treated with periarticular cooling. 2) The Blush-Control Cohort, consisting of 18 angiographies (from 18 knees) with a blush but without a cooling maneuver. 3) The No-Blush Control Cohort (11 knees). The blush area on DSA was quantitatively analyzed for both groups with a superficial blush; in the Cooling Cohort, the area was compared before and after the intervention, while the baseline blush was quantified for the Blush-Control Cohort. Skin-related adverse events were systematically recorded and compared at the patient level across all three cohorts.</p><p><strong>Results: </strong>The application of periarticular cooling resulted in a significant reduction in the mean blush area from 464.8 ± 447.6 mm<sup>2</sup> to 240.1 ± 208.2 mm<sup>2</sup> (p = 0.012), corresponding to an average reduction of 73.8% (p = 0.0006). Patients receiving cooling showed significantly fewer skin alterations than the blush-control group [median score 1 vs 2, p = 0.0174].</p><p><strong>Conclusion: </strong>Periarticular cooling is a simple, non-invasive, and effective technique that significantly reduces quantifiable non-target cutaneous perfusion during GAE. Our work provides objective evidence supporting its use as a standard safety-enhancing maneuver to minimize the risk of skin-related complications.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"73"},"PeriodicalIF":1.5,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12474841/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145151943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-26DOI: 10.1186/s42155-025-00595-2
Yoshinori Tsubakimoto, Jun Shiraishi, Daisuke Usuki, Shin Takiuchi, Satoru Otsuji
Background: Endovascular therapy (EVT) has become a key revascularization strategy for patients with chronic limb-threatening ischemia (CLTI), especially in cases involving infrapopliteal (IP) chronic total occlusions (CTOs), which are often challenging to treat using standard antegrade approaches alone. Trans-collateral angioplasty (TCA) is a retrograde technique that accesses the distal true lumen via collateral vessels when conventional methods are unsuccessful. However, clinical evidence regarding the efficacy and safety of TCA remains insufficient. This study aimed to evaluate the efficacy and safety of TCA as a retrograde approach during EVT for IP CTO lesions.
Results: This retrospective single-center study included 44 IP CTO lesions in patients who underwent TCA between January 2020 and December 2022, after excluding 18 lesions treated solely with the pedal-plantar loop technique. The mean patient age was 78.8 years, and 81.8% had diabetes, 79.5% had chronic kidney disease, and 31.8% were on dialysis. EVT success was achieved in 95.5% (95% CI: 84.9-98.7) of lesions. TCA alone achieved lesion crossing in 70.5% (95% CI: 55.8-81.8), while distal puncture was required in 13.6% (95% CI: 6.4-27.0) of cases. Various crossing techniques, including the rendezvous technique and reverse subintimal tracking, were conducted. Collateral vessel-related complications occurred in 11.3% (5 lesions; 95% CI: 5.0-24.6), including injury in 6.8%, and occlusion and spasm in 2.3%. No vessel dissections occurred. The overall incidence of perioperative complications within 30 days was 20.5% (95% CI: 11.3-34.2), most commonly gastrointestinal bleeding and stroke. At one year, the rate of freedom from target lesion revascularization was 45.4%, and amputation-free survival was 84.0%.
Conclusions: Our findings suggest that TCA can be a feasible and relatively safe retrograde strategy for complex IP CTO lesions when antegrade wiring fails. It is associated with high procedural success and a low incidence of collateral vessel-related complications, supporting its use in selected cases of CLTI.
{"title":"Efficacy and safety of Trans-collateral revascularization of infrapopliteal vessels: A Single-center retrospective study.","authors":"Yoshinori Tsubakimoto, Jun Shiraishi, Daisuke Usuki, Shin Takiuchi, Satoru Otsuji","doi":"10.1186/s42155-025-00595-2","DOIUrl":"10.1186/s42155-025-00595-2","url":null,"abstract":"<p><strong>Background: </strong>Endovascular therapy (EVT) has become a key revascularization strategy for patients with chronic limb-threatening ischemia (CLTI), especially in cases involving infrapopliteal (IP) chronic total occlusions (CTOs), which are often challenging to treat using standard antegrade approaches alone. Trans-collateral angioplasty (TCA) is a retrograde technique that accesses the distal true lumen via collateral vessels when conventional methods are unsuccessful. However, clinical evidence regarding the efficacy and safety of TCA remains insufficient. This study aimed to evaluate the efficacy and safety of TCA as a retrograde approach during EVT for IP CTO lesions.</p><p><strong>Results: </strong>This retrospective single-center study included 44 IP CTO lesions in patients who underwent TCA between January 2020 and December 2022, after excluding 18 lesions treated solely with the pedal-plantar loop technique. The mean patient age was 78.8 years, and 81.8% had diabetes, 79.5% had chronic kidney disease, and 31.8% were on dialysis. EVT success was achieved in 95.5% (95% CI: 84.9-98.7) of lesions. TCA alone achieved lesion crossing in 70.5% (95% CI: 55.8-81.8), while distal puncture was required in 13.6% (95% CI: 6.4-27.0) of cases. Various crossing techniques, including the rendezvous technique and reverse subintimal tracking, were conducted. Collateral vessel-related complications occurred in 11.3% (5 lesions; 95% CI: 5.0-24.6), including injury in 6.8%, and occlusion and spasm in 2.3%. No vessel dissections occurred. The overall incidence of perioperative complications within 30 days was 20.5% (95% CI: 11.3-34.2), most commonly gastrointestinal bleeding and stroke. At one year, the rate of freedom from target lesion revascularization was 45.4%, and amputation-free survival was 84.0%.</p><p><strong>Conclusions: </strong>Our findings suggest that TCA can be a feasible and relatively safe retrograde strategy for complex IP CTO lesions when antegrade wiring fails. It is associated with high procedural success and a low incidence of collateral vessel-related complications, supporting its use in selected cases of CLTI.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"72"},"PeriodicalIF":1.5,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12474752/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145152007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01DOI: 10.1186/s42155-025-00598-z
Jim A Reekers
{"title":"A few final thoughts as outgoing editor-in-chief.","authors":"Jim A Reekers","doi":"10.1186/s42155-025-00598-z","DOIUrl":"10.1186/s42155-025-00598-z","url":null,"abstract":"","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"71"},"PeriodicalIF":1.5,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401832/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144978153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-29DOI: 10.1186/s42155-025-00590-7
Jonathan C Giang, Dillon M Brown, Jeffrey Forris Beecham Chick, Eric J Monroe, David S Shin, Mina S Makary
{"title":"Bifurcated hepatocaval stent reconstruction for treatment of hepatic venous outflow obstruction in orthotopic liver transplantation.","authors":"Jonathan C Giang, Dillon M Brown, Jeffrey Forris Beecham Chick, Eric J Monroe, David S Shin, Mina S Makary","doi":"10.1186/s42155-025-00590-7","DOIUrl":"10.1186/s42155-025-00590-7","url":null,"abstract":"","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"70"},"PeriodicalIF":1.5,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12397019/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144978162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Post-operative portal vein stenosis/occlusion is a relatively common and life-threatening condition. Clinical outcomes depend on the early diagnosis and the appropriate management.
Case presentation: A 78-year-old female developed portal vein high grade stenosis after resection of an ampullary cholangiocarcinoma. The patient presented with acute liver failure and impaired coagulation function. Imaging confirmed transient ischemic changes of the hepatic parenchyma. Salvage attempt with a portal venous stent was decided to prevent irreversible liver damage. The procedure was successful with a satisfactory clinical outcome.
Conclusions: The paper offers a summary of the clinical benefit from percutaneous portal venous stent placement in case of post operative high grade portal vein stenosis in a patient with acute liver failure.
{"title":"Portal vein stent to save the day.","authors":"Panagiotis Grigoropoulos, Vasilina Tsemelidi, Orfeas Varvarelis, Antonios Vezakis, Achilles Chatziioannou, Miltiadis Krokidis","doi":"10.1186/s42155-025-00586-3","DOIUrl":"10.1186/s42155-025-00586-3","url":null,"abstract":"<p><strong>Background: </strong>Post-operative portal vein stenosis/occlusion is a relatively common and life-threatening condition. Clinical outcomes depend on the early diagnosis and the appropriate management.</p><p><strong>Case presentation: </strong>A 78-year-old female developed portal vein high grade stenosis after resection of an ampullary cholangiocarcinoma. The patient presented with acute liver failure and impaired coagulation function. Imaging confirmed transient ischemic changes of the hepatic parenchyma. Salvage attempt with a portal venous stent was decided to prevent irreversible liver damage. The procedure was successful with a satisfactory clinical outcome.</p><p><strong>Conclusions: </strong>The paper offers a summary of the clinical benefit from percutaneous portal venous stent placement in case of post operative high grade portal vein stenosis in a patient with acute liver failure.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"69"},"PeriodicalIF":1.5,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12397468/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144977457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-22DOI: 10.1186/s42155-025-00563-w
Taha Yusuf Kuzan, Rüçhan Anbar
Subcutaneously implanted port catheters are increasingly used in the management of long-term chemotherapy and provide great comfort to oncology patients. Although central venous ports are implanted with high technical success and low complication rates, catheter malposition may occur, resulting in port dysfunction. Various techniques exist for repositioning malpositioned catheters. This report describes the use of an artificial snare technique for the repositioning of a central venous port catheter that was identified as malpositioned six months following its insertion.
{"title":"Artificial snare technique for transfemoral repositioning of malpositioned central venous port catheter.","authors":"Taha Yusuf Kuzan, Rüçhan Anbar","doi":"10.1186/s42155-025-00563-w","DOIUrl":"10.1186/s42155-025-00563-w","url":null,"abstract":"<p><p>Subcutaneously implanted port catheters are increasingly used in the management of long-term chemotherapy and provide great comfort to oncology patients. Although central venous ports are implanted with high technical success and low complication rates, catheter malposition may occur, resulting in port dysfunction. Various techniques exist for repositioning malpositioned catheters. This report describes the use of an artificial snare technique for the repositioning of a central venous port catheter that was identified as malpositioned six months following its insertion.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"68"},"PeriodicalIF":1.5,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12370592/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144978239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-19DOI: 10.1186/s42155-025-00587-2
Ismail Taskent, Guler Gulsen Ersoy
Background: Arteriovenous fistula (AVF) thrombosis remains a critical complication in hemodialysis (HD) patients, often leading to treatment delays and requiring urgent intervention. While endovascular therapy (EVT) is commonly employed, less invasive strategies such as percutaneous thrombolytic therapy are gaining attention due to their potential to restore patency and avoid more complex procedures. This study assessed the effectiveness of percutaneous thrombolytic therapy in acute AVF thrombosis and explored key predictors associated with the need for subsequent endovascular intervention.
Methods: This retrospective study included 42 patients who underwent ultrasound-guided percutaneous thrombolytic therapy using low-dose alteplase (3-5 mg). Technical and clinical success, complication rates, and the need for additional EVT were assessed. Statistical analyses including logistic regression and ROC analysis were used to determine independent predictors for EVT.
Results: The clinical success rate was 97.6%, with 69% of patients achieving AVF patency without EVT. Symptom duration emerged as the strongest predictor for EVT; patients with symptoms > 2.5 days had significantly higher EVT rates (p = 0.01). Each additional day of symptoms increased the odds of requiring EVT by 88.5% (OR = 1.885, p = 0.012). Female patients were also more likely to require EVT than males (p = 0.005). No significant associations were found for age, BMI, or fistula characteristics.
Conclusion: Percutaneous thrombolytic therapy is a highly effective and minimally invasive option for acute AVF thrombosis. Symptom duration > 2.5 days is a key threshold predicting the need for EVT, highlighting the critical importance of early intervention. These findings may inform clinical decision-making and optimize access salvage strategies in dialysis patients.
{"title":"Early percutaneous thrombolysis for AVF thrombosis: symptom duration as a predictor of endovascular salvage.","authors":"Ismail Taskent, Guler Gulsen Ersoy","doi":"10.1186/s42155-025-00587-2","DOIUrl":"10.1186/s42155-025-00587-2","url":null,"abstract":"<p><strong>Background: </strong>Arteriovenous fistula (AVF) thrombosis remains a critical complication in hemodialysis (HD) patients, often leading to treatment delays and requiring urgent intervention. While endovascular therapy (EVT) is commonly employed, less invasive strategies such as percutaneous thrombolytic therapy are gaining attention due to their potential to restore patency and avoid more complex procedures. This study assessed the effectiveness of percutaneous thrombolytic therapy in acute AVF thrombosis and explored key predictors associated with the need for subsequent endovascular intervention.</p><p><strong>Methods: </strong>This retrospective study included 42 patients who underwent ultrasound-guided percutaneous thrombolytic therapy using low-dose alteplase (3-5 mg). Technical and clinical success, complication rates, and the need for additional EVT were assessed. Statistical analyses including logistic regression and ROC analysis were used to determine independent predictors for EVT.</p><p><strong>Results: </strong>The clinical success rate was 97.6%, with 69% of patients achieving AVF patency without EVT. Symptom duration emerged as the strongest predictor for EVT; patients with symptoms > 2.5 days had significantly higher EVT rates (p = 0.01). Each additional day of symptoms increased the odds of requiring EVT by 88.5% (OR = 1.885, p = 0.012). Female patients were also more likely to require EVT than males (p = 0.005). No significant associations were found for age, BMI, or fistula characteristics.</p><p><strong>Conclusion: </strong>Percutaneous thrombolytic therapy is a highly effective and minimally invasive option for acute AVF thrombosis. Symptom duration > 2.5 days is a key threshold predicting the need for EVT, highlighting the critical importance of early intervention. These findings may inform clinical decision-making and optimize access salvage strategies in dialysis patients.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"67"},"PeriodicalIF":1.5,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12364786/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144876724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-16DOI: 10.1186/s42155-025-00583-6
Shinsuke Mori, Mitsuyoshi Takahara, Tatsuya Nakama, Kazuki Tobita, Naoki Hayakawa, Yo Iwata, Kazunori Horie, Kenji Suzuki, Norihiro Kobayashi, Yoshiaki Ito
Purpose: This study aimed to reveal the impact of nodular calcification (NC) on restenosis risk in patients undergoing femoropopliteal drug-coated balloon (DCB) angioplasty for symptomatic atherosclerotic peripheral artery disease.
Methods: We retrospectively analyzed 568 patients who underwent endovascular therapy with DCB for de novo femoropopliteal lesions under intravascular ultrasound guidance between November 2017 and February 2021 at seven cardiovascular centers in Japan. Patients with lesions without calcification were excluded from the study. The patients were classified into two groups based on the presence or absence of NC: the NC [ +] group (n = 200) and the NC [-] group (n = 368). The main outcome was the primary patency at 3 years. Cox proportional hazards analysis was used to determine whether NC was an independent predictor of clinical outcomes.
Results: The 3-year primary patency rates were significantly lower in the NC [ +] group than in the NC [-] group (53.8% vs. 65.8%, p = 0.001). After multivariate analysis, the presence of NC was independently associated with restenosis risk; the adjusted hazard ratio was 1.61 (95% confidence interval 1.15 to 2.26, p = 0.006).
Conclusion: The NC is an independent predictor of restenosis in patients undergoing DCB angioplasty for femoropopliteal lesions. Patients with NC had a significantly lower primary patency, highlighting their negative impact on clinical outcomes. Further research is required to establish evidence-based strategies for managing calcified femoropopliteal lesions.
目的:本研究旨在揭示结节钙化(NC)对行股腘药物包被球囊(DCB)血管成形术治疗症状性动脉粥样硬化性外周动脉疾病患者再狭窄风险的影响。方法:我们回顾性分析了2017年11月至2021年2月在日本7个心血管中心在血管内超声引导下接受DCB血管内治疗新发股腘病变的568例患者。无钙化病变的患者被排除在研究之外。根据有无NC分为两组:NC[+]组(n = 200)和NC[-]组(n = 368)。主要结果是3年时的原发性通畅。采用Cox比例风险分析来确定NC是否是临床结果的独立预测因子。结果:NC[+]组3年原发性通畅率明显低于NC[-]组(53.8% vs. 65.8%, p = 0.001)。多因素分析显示,NC的存在与再狭窄风险独立相关;校正后的风险比为1.61(95%置信区间1.15 ~ 2.26,p = 0.006)。结论:NC是股腘动脉病变行DCB血管成形术患者再狭窄的独立预测因子。NC患者的原发性通畅率明显较低,这突出了其对临床结果的负面影响。需要进一步的研究来建立以证据为基础的治疗股腘动脉钙化病变的策略。
{"title":"Analysis of the impact of nodular calcification on clinical outcome after drug-coated balloon angioplasty for femoropopliteal lesions.","authors":"Shinsuke Mori, Mitsuyoshi Takahara, Tatsuya Nakama, Kazuki Tobita, Naoki Hayakawa, Yo Iwata, Kazunori Horie, Kenji Suzuki, Norihiro Kobayashi, Yoshiaki Ito","doi":"10.1186/s42155-025-00583-6","DOIUrl":"10.1186/s42155-025-00583-6","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to reveal the impact of nodular calcification (NC) on restenosis risk in patients undergoing femoropopliteal drug-coated balloon (DCB) angioplasty for symptomatic atherosclerotic peripheral artery disease.</p><p><strong>Methods: </strong>We retrospectively analyzed 568 patients who underwent endovascular therapy with DCB for de novo femoropopliteal lesions under intravascular ultrasound guidance between November 2017 and February 2021 at seven cardiovascular centers in Japan. Patients with lesions without calcification were excluded from the study. The patients were classified into two groups based on the presence or absence of NC: the NC [ +] group (n = 200) and the NC [-] group (n = 368). The main outcome was the primary patency at 3 years. Cox proportional hazards analysis was used to determine whether NC was an independent predictor of clinical outcomes.</p><p><strong>Results: </strong>The 3-year primary patency rates were significantly lower in the NC [ +] group than in the NC [-] group (53.8% vs. 65.8%, p = 0.001). After multivariate analysis, the presence of NC was independently associated with restenosis risk; the adjusted hazard ratio was 1.61 (95% confidence interval 1.15 to 2.26, p = 0.006).</p><p><strong>Conclusion: </strong>The NC is an independent predictor of restenosis in patients undergoing DCB angioplasty for femoropopliteal lesions. Patients with NC had a significantly lower primary patency, highlighting their negative impact on clinical outcomes. Further research is required to establish evidence-based strategies for managing calcified femoropopliteal lesions.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"65"},"PeriodicalIF":1.5,"publicationDate":"2025-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12357817/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144859915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Endovascular therapy (EVT) is a well-established revascularization strategy for patients with peripheral artery disease. However, achieving optimal wire crossing in complex chronic total occlusion lesions remains technically challenging. Intravascular ultrasound (IVUS)-guided wiring facilitates safer and more effective procedures. However, aligning IVUS findings with fluoroscopic imaging is challenging due to catheter rotation. We report a novel technique-termed the IDEAL technique-that leverages the deep vein as an anatomical landmark to correct IVUS rotational orientation.
Case presentation: A 76-year-old female presented with chronic limb-threatening ischemia in the right toe. Contrast-enhanced computed tomography revealed a chronic total occlusion in the right superficial femoral artery. EVT was performed via the right common femoral artery. IVUS revealed that the first guidewire had entered the subintimal space partway through its course. Using preprocedural computed tomography, the deep vein was identified and its clock-face position relative to the artery was determined. This anatomical landmark enabled correction of IVUS image rotation, allowing accurate re-direction of a second guidewire under fluoroscopic guidance, thereby successfully crossing into the intraplaque lumen.
Conclusions: The IDEAL technique quickly provides anatomical orientation by utilizing the deep vein as a landmark during IVUS-guided wiring-making it, quite literally, ideal.
{"title":"IVUS-guided wiring using the deep vein as a landmark (IDEAL) technique for treating chronic total occlusions in peripheral artery disease.","authors":"Yohei Ueno, Mitsuo Sobajima, Teruhiko Imamura, Hiroshi Onoda, Ryuichi Ushijima, Hiroshi Ueno, Koichiro Kinugawa","doi":"10.1186/s42155-025-00584-5","DOIUrl":"10.1186/s42155-025-00584-5","url":null,"abstract":"<p><strong>Background: </strong>Endovascular therapy (EVT) is a well-established revascularization strategy for patients with peripheral artery disease. However, achieving optimal wire crossing in complex chronic total occlusion lesions remains technically challenging. Intravascular ultrasound (IVUS)-guided wiring facilitates safer and more effective procedures. However, aligning IVUS findings with fluoroscopic imaging is challenging due to catheter rotation. We report a novel technique-termed the IDEAL technique-that leverages the deep vein as an anatomical landmark to correct IVUS rotational orientation.</p><p><strong>Case presentation: </strong>A 76-year-old female presented with chronic limb-threatening ischemia in the right toe. Contrast-enhanced computed tomography revealed a chronic total occlusion in the right superficial femoral artery. EVT was performed via the right common femoral artery. IVUS revealed that the first guidewire had entered the subintimal space partway through its course. Using preprocedural computed tomography, the deep vein was identified and its clock-face position relative to the artery was determined. This anatomical landmark enabled correction of IVUS image rotation, allowing accurate re-direction of a second guidewire under fluoroscopic guidance, thereby successfully crossing into the intraplaque lumen.</p><p><strong>Conclusions: </strong>The IDEAL technique quickly provides anatomical orientation by utilizing the deep vein as a landmark during IVUS-guided wiring-making it, quite literally, ideal.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"64"},"PeriodicalIF":1.5,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12354929/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144857020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}